SPY328.26+1.74 0.53%
DIA265.79+1.44 0.54%
IXIC10,856.01+110.74 1.03%

Gilead Reports Submission Of Filgotinib New Drug Application Under Priority Review For Rheumatoid Arthritis Treatment

Benzinga · -